Home Page

Emergent's mission is simple—
to protect and enhance life.

As a global specialty pharmaceutical company,
Emergent offers specialized products to
healthcare providers and governments to
address medical needs and emerging
health threats.

Learn More

sBLA Submitted for FDA
Approval of Large-Scale
Manufacturing of BioThrax
in Building 55

LEARN MORE ▶

Emergent BioSolutions
Announces Filing of Form 10
Registration Statement for Its
Planned Spin-Off of Its Biosciences
Business Aptevo Therapeutics

LEARN MORE ▶

Emergard Auto-Injector Platform
for Nerve Agent Antidote Delivery
Selected by U.S. Department of
Defense and Battelle
for Testing and Development

LEARN MORE ▶

Meet Us

  • Investor Relations

    Robert W. Baird Healthcare Conference
    September 7-8, 2016
    New York, NY

     

  • Investor Relations

    Wells Fargo Healthcare Conference
    September 7-8, 2016
    Boston, MA

     

  • Investor Relations

    Three Part Advisors
    Midwest IDEAS Conference
    August 30-31, 2016
    Chicago, IL

     

  • Investor Relations

    Three Part Advisors
    East Coast IDEAS Conference
    June 28-29, 2016
    Boston, MA

     

  • Investor Relations

    Jefferies Healthcare Conference
    June 7-10, 2016
    New York, NY

     

Price $42.93 -0.22 (-0.51%)
 May 27 2016 9:40AM

REFRESH